Exempt specimens
ADR Regulations for shipping exempt human and animal specimens
Human or animal specimens for which there is minimal likelihood that pathogens are present are not subject to ADR if the specimen is carried in a packaging which will prevent any leakage and which is marked with the words "Exempt human specimen" or "Exempt animal specimen", as appropriate.
The packaging is deemed to comply with the above requirements if it meets the following conditions:

(a) The packaging consists of three components:
(i) a leak-proof primary receptacle(s);
(ii) a leak-proof secondary packaging; and
(iii) an outer packaging of adequate strength for its capacity, mass and intended use, and with at least one surface having minimum dimensions of 100 mm x 100 mm;
(iii) an outer packaging of adequate strength for its capacity, mass and intended use, and with at least one surface having minimum dimensions of 100 mm x 100 mm;

(b) For liquids, absorbent material in sufficient quantity to absorb the entire contents is placed between the primary receptacle(s) and the secondary packaging so that, during carriage, any release or leak of a liquid
substance will not reach the outer packaging and will not compromise the integrity of the cushioning material;

(c) When multiple fragile primary receptacles are placed in a single secondary packaging, they are either individually wrapped or separated to prevent contact between them.

NOTE 1: An element of professional judgment is required to determine if a substance is exempt under this paragraph. That judgment should be based on the known medical history, symptoms and individual circumstances of the source, human or animal, and endemic local conditions.
Examples of specimens which may be carried under this paragraph include:
- the blood or urine tests to monitor cholesterol levels, blood glucose levels, hormone levels, or prostate specific antibodies (PSA);
- those required to monitor organ function such as heart, liver or kidney function for humans or animals with non-infectious diseases, or for therapeutic drug monitoring;
- those conducted for insurance or employment purposes and are intended to determine the presence of drugs or alcohol;
- pregnancy test;
- biopsies to detect cancer;
-antibody detection in humans or animals in the absence of any concern for infection (e.g. evaluation of vaccine induced immunity, diagnosis of autoimmune disease,etc.).

NOTA 2: For air transport, packagings for specimens exempted under this paragraph shall meet the conditions in (a) to (c).

2.2.62.1.5.7 Except for:
(a) Medical waste (UN No. 3291);
(b) Medical devices or equipment contaminated with or containing infectious substances in Category A (UN No. 2814 or UN No. 2900);
(c) Medical devices or equipment contaminated with or containing other dangerous goods that meet the definition of another class